ebook img

Respiratory Medicine 2002: Vol 96 Index PDF

17 Pages·2002·3.6 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Respiratory Medicine 2002: Vol 96 Index

MEDICINE Index Volume 96, 2002 ELSEVIER SCIENCE LTD Copyright © 2002 Elsevier Science Ltd ALL RIGHTS RESERVED No part of this volume may be reproduced in any form, by photostat, microfilm, or any other means, without written permission from the publishers respiratoryMEDICINE Index to Volume 96 99mTc-DTPA, kinetics of lung clearance in smoking pa- Amsellem, C. 244 tients with sarcoidosis compared to healthy smokers 31 Amygdalou, A. 268, 499 Anderson, R. 582 xl-anti-trypsin phenotypes, deficient: influence on clini- Andersson, F. 700 cal characteristics and severity of asthma in adults 186 Andersson, |. 944 Accuhaler “, salmeterol, versus eformoterol Turboha- Andersson. M. 24 ler“ with symptomatic asthma, cost effectiveness 250 Ando, M. 18 adenose deaminase 2 (ADA?) activity in adults: useful- Angus, R. 963 ness for the diagnosis of pulmonary tuberculosis 607 Ansola, P. 812 adenosine deaminase activity in bron hoalveolar lavage in Anthony, R. E. 31 Turkish patients with smear negative pulmonary tu- Argyropoulou, P. 594 berculosis 536 Arimura, K. 817 adenosine deaminase activity in sputum, diagnostic value Arseven,O . 515 in pulmonary tuberculosis 632 Arshad, S. H. 163 Agusti, A.G. N. 193 Arvidsson, M. 1040 Ahlstedt, S. 95 Ailani, R 805 assisted ventilation, lack of additional effect adjunct of to pulmonary rehabilitation in mild COPD patients 359 Ailani, R. K. 805 asthma: a proposal for a practical treatment guideline Airmax'™: bronchodilating effects of salbutamol from a novel inhaler 493 designed for the initial two hours of the management :delivery of formoterol from a novel multi-dose inha- of patients with acute severe asthma and COPD using ler 397 the principles of evidence-based medicine 659 :effects of 4-week treatment with low-dose budeso- rand asthma-like disorder: a 5-year follow-up study 1040 nide (100 tty BID) from a novel inhaler and from a con- ventional inhaler on bronchial hyper-responsiveness, :and wheezing illnesses, prevalence amongst |0-year- lung function and symptoms on patients with mild old schoolchildren 163 asthma 542 ‘applying evidence and theory to guide clinical decision slung deposition of budesonide 389 making — implications for asthma management 567 :salbutamol and budesonide, delivery from a novel assessment of severity and treatment by GPs in Bel- multi-dose inhaler 404 gium 170 Akahori, 469 :barriers in the management of asthma and attitudes Akkaya, E. 519 towards complementary medicine 835 Al-Attia, H. M. 846 :blood eosinophil counts for the prediction of the se- Aldons, P. M. 862 verity of exercise-induced bronchspasm 120 Aldrich,T .K . 984 :comparison of second controller medications in addi- Aldridge, R. E. 950 tion to inhaled corticosteroid in patients with moder- Alexandrakis, M. G. 553 ate asthma 322 Alimchandani, A. 805 ‘comparison of two budesonide powder inhalers, Allen, M. 963 Easyhaler “ and Turbuhaler “, in steroid-nave asth- allergen, inhaled: ambient level of NO augments the in- matic patients 599 flammatory response to in asthmatics 907 :control and differences in management practices allergen avoidance effect of, lung function predictors in across seven European countries 142 infants at high risk of atopy: 230 :differences in trigger factors and symptoms between allergen sensitization and allergen exposure in Greenlan- patients with asthma-like symptoms and patients der Inuit residing in Denmark and Greenland 736 with asthma: development of a basis for a question- alpha-l-antitrypsin deficiency: smoking, decline in lung naire 305 function and implications for therapeutic trials 872 :dyspnea, respiratory function and sputum profile in Alvarez-Sala, J. L. 487 asthmatic patients during exacerbations 745 Ambrosino, N. 312, 359 :effect of deep inhalations after a bronchial methacho- Amir,G . 890 line provocation in asthmatic and non-asthmatic pa- amoxicillin/clavanulate: telithromycin is as effective in tients 477 acute exacerbations of chronic obstructive pulmonary :effect of ozone on bronchial mucosal inflammation in disease 862 asthmatic and healthy patients 352 :effects of 4-week treatment with low-dose budeso- ‘severity, allergy and lung function during young mid- nide (100 tty BID) from a novel inhaler Airmax'™ and dle life in subjects with asthma in childhood 716 from a conventional inhaler on bronchial hyper-re- ‘short-term effectivieness of an asthma educational sponsiveness, lung function and symptoms on patients programme: results of a randomized controlled trial with mild asthma 542 993 :effects of regular inhaled formoterol and budesonide :symptomatic: attendance and prescribing in general on preformed Th-2 cytokines in mild asthmatics 1021 practice 102 :evaluation of different inhaled combination therapies ‘treatment of acute severe asthma and chronic ob- (EDICT): a randomised, double-blind comparison of structive pulmonary disease in Seretide '™ (50/250 jg bd) Diskus" vs. formoterol Danish hospitals: do national recommendations improve and budesonide (800 1g bd) given concurrently (both on the quality of the treatment? 653 via Turbuhaler’) with moderate- to-severe asthma ‘treatment with herbal medicine T]-96: a randomized 85! controlled trial 469 -evaluation of long-term efficiency of an asthma educa- :up-regulation of heme oxygenase-| in alveolar macro- tion programme in an out-patient clinic 519 phages of newly- diagnosed asthmatics 418 exhaled nitric oxide, short-term variability in young asthma, allergic: is the increase in bronchial responsive- male patients with mild asthma in healthy subjects 895 ness or FEVI shortly after cessation of [}2-agonists re- high prevalence of obesity in asthmatic patients on flecting a real deterioration of the disease? A sick leave 642 comparison between short-acting and long-acting ‘incidence rates and risk factors for asthma among (}2-agonists 155 schoolchildren: a 2-year follow-up 1006 asthma, childhood: HPA-axis effects of nebulised flutica- ‘inflammatory marker serum eosinophil cationic pro- sone propionate compared with oral prednisolone in tein (ECP) compared with PEF as a tool to decide in- 625 haled corticosteroid dose in asthmatic patients 95 asthma, occupational, flour-induced, diagnosis in a cross- :influence of deficient xl-anti-trypsin phenotypes on sectional study 236 clinical characteristics and severity in adults 186 asthma, symptomatic: eformoterol Turbohaler “ versus ‘investigative bronchoscopy and endobronchial biopsy salmeterol Accuhaler “, cost effectiveness 250 is well tolerated in hyperreactive asthma patients 466 atopy: lung function predictors in infants at high risk of: :natural allergen exposure does not diminish the sensi- effect of allergen avoidance 230 tivity of cytokine production to glucocorticosteroids :serum eosinophil cationic protein (S-ECP) in a popula- in blood cells of seasonal allergic asthma and rhinitis tion with low prevalence of 525 927 Aubier, M. 862 :nitric oxide analysis applied to patients with COPD, Aziz, |. 548 allergic asthma and allergic rhinitis 24 :nitrous oxide: ambient level augments the inflamma- (32-agonists: is the increase in bronchial responsiveness tory response to inhaled allergen in asthmatics 907 or FEVI shortly after cessation reflecting a real dete- :pilot study examining the relationship between stress rioration of allergic asthma? A comparison between and serum cortisol concentrations in women with short-acting and long-acting ?(}2-agonists 155 asthma 823 Baccheschi,J . 110 :prevalence and risk for asthma and chronic bronchitis Bach, P. B. 280 in the capitals Helsinki, Stockholm and Tallinn 759 Bachour, A. 586 :prevalence with allergic rhinitis and eczema among Backer, V. 736 university students in Bangkok 34 Bailey,W .C . 444 :prospective, placebo-controlled trial of 5 vs I0 days of Bakir, K. 275 oral prednisolone in acute adult asthma 950 Bakke, P. S. 424 :relationship between patient and disease characteris- Balachandran, D. !78 tics, and health-related quality of life in adults with Balcells, E. 186 asthma 450 BALF N-acetylglucosaminidase and {3-galactosidase ac- :relative therapeutic index between inhaled formoter- tivities in idiopathic pulmonary fibrosis 75] ol and salbutamol in asthma patients 412 Banno, S. 770 ‘rhinitis increases the risk for adult-onset asthma — a Barbe, F. 193 Swedish population-based case-control study (MAF- Barcelo, A. 193 study) 635 Barck, C. 907 ‘safety, tolerability and acceptability of two dry pow- Barnacle, H. 625 der inhalers in the administration of budesonide in Barnes, N. 963 steroid-treated asthmatic patients 221 Barrett-Connor, E. 796 Barrientos, A. 487 Brudin, L. 115 Barta, S.K. 375 BrugnamGi. ,99 3 Beder, S. 536 Buckley, J. 805 Behrakis, P. 268 budesonide : and salbutamol, delivery from a novel multi- Behrakis, P. K. 499 dose inhaler Airmax’ 404 Bellia,V .8 81 slung deposition from the novel dry powder inhaler Bende, M. 731 Airmax'™ 389 Benotti, P. N. 672 budesonide (100 tty BID) low-dose: effects of 4-week Bensi,G . 881 treatment from a novel inhaler Airmax'™ and from a Benvenuti, A. 236 conventional inhaler on bronchial hyper-responsive- Berkman, N. 890 ness, lung function and symptoms on patients with Bianchi Martini, L. 236 mild asthma 542 Bianchi, L. 312, 359 budesonide (800 tig bd) and formoterol given concur- Bianchi, R. 745 rently (both via Turbuhaler’™) vs evaluation of differ- Bianco, S. 881 ent inhaled combination therapies (EDICT): a Bienfait-Beuzon, C. 862 randomised, double-blind comparison of Seretide Biesterfeld, S. 87 (50/250 j1g bd) Diskus’ with moderate- to-severe Bijl-Hofland, |. D. 155 asthma 85 biopsy, closed pleural needle: predicting diagnostic yield budesonide administration: safety, tolerability and ac- by examining pleural fluid 890 ceptability of two dry powder inhalers in steroid-trea- biopsy, endobronchial, and investigative bronchoscopy ted asthmatic patients 221 is well tolerated in hyperreactive asthma patients budesonide and formoterol, effects of regular inhalation 466 on preformed Th-2 cytokines in mild asthmatics 1021 Bjarneman, P. 305 budesonide or theophylline: effect of long-term treat- Bjermer, L. 796 ment on lung function, airway reactivity and asthma Bjorkstén, B. 525 symptoms 432 Blomberg, A. 352 budesonide powder inhalers, Easyhaler ~ and Turbuha- Blom-Bulow, B. 317 ler", comparison in steroid-nave asthmatic patients 599 Bocskei, C. 412 BusseW., W . 293 Boman, G. 525 Bylin,G . 907 Borg, S. 700 Byrd, R. P. 672 Bortesi, M. L. 215 Bouros, D. 553 Caglayan, B. 677 Brackel, H. J. L. 976 Cakan, M.D. A. 506 Bradvik, |. 317 Califano, C. 790 Bratel,T .9 34 Calisir, H.C. 322 Breuer, R. 890 Cantini, L. 784 Brianti, M. 215 capsaicin inhalation test for identification of sensory Broberg, P. 927 hyperreactivity 731 bronchial hyperreactivity, role of TNF-% and its 55 and 75 Carldstedt, I. 81 kDa receptors 262 Carlucci, P. 137 bronchial mucosal inflammation: effect of ozone in asth- Carrara, M. 236 matic and healthy patients 352 Carty, S. M. 31 bronchiectasis: relationship between psychological well- Casanova, S. 137 being and lung health status in patients with 686 Casciola, G. 993 bronchiolitis obliteran organizing pneumonia in cancer: a Castagna, F. 137, 439 case series 280 Cazzola, M. 137, 439, 790 bronchitis, chronic: quality of life in acute exacerbation: Centanni, S. 137, 439 results from a German population study 39 cephalosporin-resistant pneumococcal pneumonia: does bronchitis: prevalence and risk for asthma and chronic it affect outcome? 805 bronchitis in the capitals Helsinki, Stockholm and Tal- Ceyhan, B. B. 61 linn 759 Chambe, M.-T. 244 bronchodilator response, expression: comparison of four Chhabra, S. K. 6ll indices 6ll Choi, |. S. 120, 150 bronchoscopy, investigative, and endobronchial biopsy is cholecystectomy, laparoscopic, respiratory system me- well tolerated in hyperreactive asthma patients 466 chanics during 268 RESPIRATORY MEDICINE Chovan, L. 851 ‘tumor necrosis factor — alpha serum levels, weight Christensen, G. 901 loss and tissue oxygenation in 594 Christensen, L. K. 653, 659 :urinary desmosine excretion in acute exacerbations Christian, J. 31 of COPD: a preliminary report I10 Christion, R. D. 450 :why developed by so few smokers? 615 chronic obstructive pulmonary disease: a proposal for a Chuchalin, A. 851 practical treatment guideline designed for the initial Chung, F. 963 two hours of the management of patients with acute Chung, K. F. 81 severe asthma and COPD using the principles of evi- Cioppa, G. D. 1021 dence-based medicine 659 Clark, D. A. 389 ‘acute effects of higher than customary doses of sal- Clausen, J. 796 meterol and salbutamol with acute exacerbation of Clini, E. 312 790 clonezapam combined with nasal CPAP, efficacy on poly- :addition of an extra dose of salmeterol Diskus“ to somnographic variables in high leg motor activity in conventional dose of salmeterol Diskus " in patients sleep apnea hypopnea patients 693 with COPD 439 Cloosterman, S.G. M. 155 :cost-benefit and cost-effectiveness analysis of self- Cockeran, R. 582 management in patients with COPD — a |-year fol- Cole, P. 582 low-up randomised, controlled trial 424 Cole, P. |. 686 :costs of exacerbations 700 Colledge, J. 397, 404 :does inspiratory behaviour affect the efficiency of complementary medicine, barriers in the management non-invasive ventilation? 709 of asthma and attitudes towards 835 :effect of oxolamine on cough sensitivity in COPD pa- Compte, L. 777 tients (SR) 6l Conde, M. B. 607 :effects of formoterol (Oxis “ Turbuhaler" ) and ipra- Connett, J. E. 444 tropium on exercise capacity in patients with 559 Constantopoulos, S. H. 499 :frequency of deep venous thrombosis and pulmonary Cooper, D. 872 embolus in acute exacerbation 515 Corless, J. A. 59 ‘individual dietary intervention in patients with COPD Coronel, F. 487 during multidisciplinary rehabilitation 330 Corris, P. 963 ‘lack of additional effect of adjunct of assisted ventila- Corris, P. A. 67 tion to pulmonary rehabilitation in mild COPD pa- corticosteroid, inhaled, comparison of second controller tients 359 medications in addition to in patients with moderate :long-term oxygen therapy and quality of life in elderly asthma 322 patients hospitalised due to exacerbation of 944 Costello, R. W. 823 ‘nitric oxide analysis applied to patients with COPD, cough sensitivity: effect of oxolamine in COPD patients allergic asthma and allergic rhinitis 24 (SR) 61 :nitric oxide, exhaled, and exercise tolerance in severe Crawford, A. 375 COPD patients 312 Creemers, J. P.H. M. 197 :normocapnia during nIPPV in chronic hypercapnic Crohn's disease and ulcerative colitis, activity related in- COPD reduces subsequent spontaneous PaCO, 572 crease in exhaled nitric oxide: a manifestation of sys- :oxitropium bromide, theophylline and their combina- temic involvement? 530 tions in COPD patients: a double-blind, randomized Cseh, K. 262 multicentre study (BREATH trial) 881 Cserhati, E. 262 :oxitropium bromide: bronchodilating effect in heart Cuhadaroglu,© . 515 disease patients with exacerbations of COPD: dou- Curbow, B. A. 823 ble-blind, randomized, controlled study 137 Curradi, F. 993 :quality of life and functional parameters in patients cystic fibrosis: demographic transition of the Swedish with COPD: an update 373 community — results of modern care 681 ‘safety of sputum induction in moderate-to-severe expression of MUCSAC and MUCSB mucins in nor- 482 mal and cystic fibrosis lungs 81 ‘telithromycin is as effective as amoxicillin/clavanulate expression of Fas and CD40 and induction of in acute exacerbations of 862 apoptosis in human cystic fibrosis airway epithelial ‘treatment of acute severe asthma and COPD in Dan- cells 244 ish hospitals: do national recommendations improve :peripheral decrease and pulmonary homing of on the quality of the treatment? 653 CD4+CD45RO+ helper memoryT cells 87 D’Amato, G. 790 :respiratory function and sputum profile in asthmatic D’Amato, M. 790 patients during exacerbations 745 Dahl, R. 432 :perception: relationship with airway inflammatory Dakin, K. S. 31 markers 150 Dalavanga,Y . A. 499 Easyhaler “ and Turbuhaler “, budesonide powder inha- Daley-Yates, P. 625 lers, comparison in steroid- nave asthmatic patients Dalton, M. 990 599 Davies, P. D.O. 59 Eaton,T . 204 De Backer, W. A. 95 Ebeo, C.T . 672 De Carvalho Kallas, F. 51! Ece,T . 515 De Fatima Pereira, M. 607 eczema: prevalence with allergic rhinitis and asthma de la Roza, C. 186 among university students in Bangkok 34 De Maertelaer, V. 693 Edlund,T . 209 De Vuyst, P. 170 eformoterol Turbohaler “ versus salmeterol Accuhaler'' De, S. 6ll with symptomatic asthma, cost effectiveness 250 decision making, clinical, applying evidence and theory — Efthimiou, J. 625 implications for asthma management 567 Eide, G. E. 1033 deep venous thrombosis and pulmonary embolus, fre- Eimoto,T .7 70 quency in acute exacerbation of chronic obstructive Ekroos, H. 895 pulmonary disease 515 El Khawand, C. 709 Dekhuijzen, P. N. R. 197 El-Abassi, R. N. 846 Del Borello, P. 215 Elborn, J. S. 841 Delaney, D. 178 Ellidokus, M. D. H. 506 Delaunois, L. 709 Elmaghraby, Z. 672 Delibalta, M. 536 Emtner, M. 24 Demedts, M. 979 end-expiratory pressure: evaluation by multiple linear Dennis, P. M. 31 regression and Fourier analysis in humans 499 Deshpande, K. S. 984 Engstrom, C.-P. 330 desmosine excretion, urinary, in acute exacerbations of Enkaya, |. 275 COPD: a preliminary report I10 Enright, P. L. 444 Devadason, S.G.990 eosinophil cationic protein (ECP) compared with PEF as Di Marco, F. 137, 439 a tool to decide inhaled corticosteroid dose in asth- Di Perna, F. 790 matic patients 95 diabetes, type |: lung function abnormalities in children eosinophilic airway inflammation as an underlying me- with 976 chanism of undiagnosed prolonged cough in primary dialysis patients, chronic, pulmonary diffusing capacity in healthcare patients 52 487 Erbag, B. 275 Diaz,G . |4 Erelel, M. 515 dietary intervention, individual, in patients with COPD Erickson, S. R. 450 during multidisciplinary rehabilitation 330 Ericsson, A. 700 DiGiovine, B. 805 Eryimaz,T .6 32 Dilmag, A. 632 Evander, E. 317 Dinkelaker, A. 1026 Evenepoel, P. 530 Djukanovich, R. 7 Everden, P. 250 Doll, H. 39 exercise capacity in patients with chronic obstructive Domenech, R. 777 pulmonary disease, effects of formoterol (Oxis “ Tur- Donner,C . F. 95 buhaler “) and ipratropium on 559 Donovan, K. J. 129 exercise tolerance and exhaled nitric oxide in severe dry powder inhaler design, formulation and perfor- COPD patients 312 mance, evaluation 283 exercise-induced bronchspasm in asthma: blood eosino- Du Bois, R. M. 67 phil counts for the prediction of the severity of |20 Duncan, C. 625 Eynott, P.R. 8I Duprat-Lomon, I. 39 Duranti, R. 745 Faghihim M. 382 Durieu, |. 244 Farrell, D. J. 259 dyspnoea: do steroids interfere in sensation? 5]| Feldman, C. 582 RESPIRATORY MEDICINE Fenn, M. 163 glucocorticosteroids: natural allergen exposure does not fibrosis, idiopathic pulmonary, BALF N-acetylglucosami- diminish the sensitivity of cytokine production to glu- nidase and /}-galactosidase activities in 75| cocorticosteroids in blood cells of seasonal allergic Fidan, A. 677 asthma and rhinitis 927 Filho, J.T. SII Goldman, J. M. 259 Finsnes, F. 901 Golshan, M. 382 Fiorenza, D. Il0 Gorostiza, A. 812 Fisher, D. 337 Gozu, A. Akkalyoncu, B. 632 Fitzgerald, S. T.8 23 Grassi,V . 881 Fleischer, W. 1026 Grazzini, M. 373 Flood,Y . 625 Green, L. 625 flour-induced occupational asthma, diagnosis in a cross- Greenstone, M. A. 548 sectional study 236 Greiff, L. 927 fluticasone propionate, nebulised, HPA-axis effects Grey-Amante, P. 39 compared with oral prednisolone in childhood Groneberg, D. A. 8I asthma 625 Grongerg, 330 Foglio, K. 312, 359 Guariglia, A. 215 Fogue, L. 14 Gulsvik, A. 1033 Folgering, H. Th. M. 155 Gupta, R. 6ll, 835 Foresi, A. 881 Gustafsson, P. 957 formoterol: delivery from a novel multi-dose inhaler Air- Gustafsson, P. M. 716 max'"' 397 ‘inhaled: relative therapeutic index between and sal- Haahtela,T . 52, 918 butamol in asthma patients 412 Halasz, A. 262 :possibilities to enhance the peripheral lung deposition Halldén, G. 907 of the inhaled liposome corticosteroids 999 Halman, L. J. 450 formoterol (Oxis“ Turbuhaler") and ipratropium: ef- Halme, M. 466 fects on exercise capacity in patients with chronic ob- Halmerbauer,G . 230 structive pulmonary disease 559 Hamalainen, K. M. 221 formoterol and budesonide (800 jig bd) given concur- Hamm, H. 572 rently (both via Turbuhaler™) vs. Seretide '™ (50/250 Hancock, E. |, 7 ug bd) Diskus’ with moderate-to-severe asthma, Hancox, M. 842 evaluation of different inhaled combinationtherapies Hansell, D. M. 686 (EDICT): a randomised, double-blind comparison of Hansen, E. F. 653 85| Hansen, L. S. 653, 659 formoterol and budesonide, effects of regular inhalation Hansson, L. 559, 927 on preformed Th-2 cytokines in mild asthmatics 1021 Harff, G. A. 197 Forsberg, P. II5 Harju,T . 418 Frew, A. J. 352, 542 Hatem, C. 984 Frischer,T . 230 Hatzizisi, O. 594 Fujita, J. 770 Hausler, M. 87 Fukunaga, H. 817 Hedenstrom, H. 24 Heide, A. 1026 Gaber K. A. 259 Heimann, G. 87 Galdiz,| .B . 812 Helleday, R. 352 Gallefosse, F. 424 Hellgren, J. 635 Gamez,C . 487 heme oxygenase-l, up-regulation in alveolar macro- Gandola, L.95 phages of newly-diagnosed asthmatics 418 Ganotakis, E. 553 hemoptysis: a retrospective analysis of 108 cases 677 Garrod, R. 725 Hennings, E. 572 Gartner, C. 230 hepatocyte growth factor serum levels: and exhaled Ge, X. 829 breath condensate in pneumonia II5 gender differences in the impact of adolescent smoking herbal medicine T]-96 treatment of asthma: a rando- on lung function and respiratory symptoms 796 mized controlled trial 469 Gessner, C. 75l Hermansson, B. A. 635 Gigliotti, F. 373 Herrala, J. 586,999 Herrero, J. A. 487 Ja nsson, S.-A. 700 Hertog, M.G. L. 389, 542 Ja rdi, R. 186 Hidalgo, }. 805 J Hirst, P. 1026 J Hirst, P. H. 389 Jw ie, H.F 1033 histamine challenge, associated subject discomfort in a Je t spacer, a new HFA-134a propellant in the adminis- population study 990 tration of inhaled BDP via, controlled clinical trial vs Ho,} . L. 607 the conventional CFC 784 veanen, M. 24 Jiménez, D. 14 Holgate, S. 1021 Jogi, \r. 525 Holgate, S.T. 95 Johan, A. 46l Holmen, J. 796 Johansson, A. 731 Holmen,T . L. 796 Johansson, K. 944 Holmkvist,T . 24 John, M. 126 Hopkinson, L. 950 Jones, A. M. 950 Hrabec, E. 127 Jones, P.W. 567, 686 Hrabec, Z. 127 Jones, S. 397, 404 Hutchinson, J. 250 Jonsson, A.-C. 700 Hutchison, D.C. S. 872 Jonsson, L. M. 209 hydrogen peroxide: an efficient and reproducible meth- Juhasz,G . 412 od for measuring in exhaled condensate 197 Jung, K. 126 hydrogen peroxide and pneumolysin, effects alone and in combination on human ciliated epithelium tro 582 Kaewsomboon, S. 34 hyperreactivity, sensory, capsaicin inhalation test for Kallman, S. 957 identification of 731 Karaca, L. 536 hyperthyroidism and pulmonary hypertension 215 Karakurt, S. 6l Karjalainen, |. 895 ladarola, P. 110 Karnak, D. 536 infants at high risk of atopy, lung function predictors: ef- Karwam M. 984 fect of allergen avoidance 230 Kastelik, J. A. 548 Inoue, K. 817 Kattaa, H. A. 846 interferon-yinhibits eosinophilic airway inflammation Kawabato, M. 817 and leukotriene antagonism reduces the generation Kayacan,O . 536 of endothelin-! 901 Kehrt, R.955 interleukin 6 (IL 6), tumor necrosis factor-x (TNF-), and Kelly, F. J. 352 their soluble receptors, serum levels in coal workers’ Kelly, M.G . 841 pneumoconiosis 829 Kempenaers, C. 693 internet: survey of public knowledge about tuberculosis Kerstjens, H. A. M. 559 (SR) 59 Keski-Karhu,} . 221 intracellular markers, identification in induced sputum Kilinc,O . 506 and bronchoalveolar lavage samples in patients with Kinnula,V . L. 418 respiratory disorders and healthy persons 918 Kirking, D. M. 450 Inuit: allergen sensitization and allergen exposure in Kiviloog, J. 759 Greenlander Inuit residing in Denmark and Greenland Kiviniemi, P. 52 736 Kjellman, B. 716 ipratropium and formoterol (Oxis“ Turbuhaler“): ef- Klaue, S.955 fects on exercise capacity in patients with chronic ob- Knox, A. 963 structive pulmonary disease 559 Koek,G . H. 530 Iran: indoor women jobs and pulmonary risks in rural Koh,Y . |. 120 areas of Isfahan 389 Kohonen-Jalonen, P. 52 lriberri, M. 812 Korsgaard, J. 344, 736 Koskela,T . 599 Jaca,C . 812 Koskinen, M.O. 999 Jamart, J. 709 Kotasova, 784 Jang, A.-S. 150 Kovacs, M. 262 Janson,C . 525 Koziel, H. 178 RESPIRATORY MEDICINE Krishna, M. T.3 52 Lundback, B. 700, 759, 1006 Kritski, A. L. 607 lung abcess in adults: clinical comparison of immuno- Kurukulaaratchy, R. J. 163 compromised to non-immunocompromised patients Kvetan, V. 984 178 Kyriakou, D. S. 553 lung cancer patients with reactive thrombocytosis, ser- Kyriazis,G . 594 um proinflammatory cytokines and its relationship to clinical parameters in 553 Lagerstrand, L. 934 lung cancer, bronchoscopic diagnosis: cytological exami- Laitinen, L. A. 466, 759, 895 nation of the whole endobronchial brush 259 Langhammer, A. 796 lung disease: role of small airways 67 Langley, S. J. 542 lung function abnormalities in children with type | dia- Langmack, E. L. 482 betes 976 Lanini, B. 745 lung function predictors in infants at high risk of atopy: Lannefors, L. 681 effect of allergen avoidance 230 Lanquart,J . P. 693 lung function: relationship to ventilation-perfused in- Laopodis,V . 268 equality and extent of emphysema as assessed by Lapa e Silva, J. R. 607 high-resolution computed tomography 934 Larsen, B. B. 432 Lupi, A. 110 Larsson, K. 477, 642, 759 Lusuardi, M. 95 Larsson, L.95 Lyberg,T .9 01 Larsson, P. 412 lymphangioleiomyomatosis: a review of the literature | Larsson, S. 330, 927,944 lymphangioleiomyomatosis: and tuberous sclerosis 7 Larusdottir, H. 317 Laube, B. L. 823 Maasilta, P. 586 Lauren, L.C. 653, 659 McConnell, A. K. 129 Lavie, P. 337 Macfarlane, J.T. 31 Leak, A. 862 McKeith, D. D. 86 Lenney,W . 625 Macian, V. 777 Leroy, B. 862 Maggi, E. 851 leukotriene antagonism reduces the generation of en- MAGhaler dry powder inhaler, lung deposition of salbu- dothelin-! and interferon-y inhibits eosinophilic air- tamol in healthy human subjects from the 1026 way inflammation 901 Magyar, P. 262 Li, |.990 Maier,W . C. 142 Liang, D. 829 Mak, K.-H. 461 Liesker, J. J.W. 559 Malhotra, A. 337 Light, R. W. 14 Malik, S. 1026 Lim, S. 81 Malinen, A. 599 Lim, W. S. 31 Mandragos, C. 499 Linden, M. 927 Mansharamani, N. 178 Lindgren, A. 681 Marabini, A. 993 Lindqvist, A. 46 Marandi, M. M. 382 Linstow, M. L. 736 Marani,G . 215 Liu,G . 829 Margantinis,G . 553 Llompart, E. 193 Marinho, S. R. 607 Lloyd, A. 250 Marklund, S. L. 209 Lofdahl, C.-G. 927 Marsico, S. A. 790 Loit, H.-M. 759 Martin, R. J. 482 London Chest Activity of Daily Living: evaluation of the Martinez Garcia, M. A. 777 reliability and sensitivity 725 Martinez,J . A. B. Sil Lorenz, J. 39 Marvisi, M. 215 lower respiratory tract infections: intensified microbio- Matera, M.G . 439, 790 logical investigations in adult patients 344 Matsuyama,W. 817 Lowhagen, O. 95, 305, 731, 1040 Matthews, S. 163 Lui,J .6 72 Matthys, H. 572 Luisetti, M. 110 Mavrofridis, E. 594 Lundahl,| .9 07 Meren, M. 759

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.